Laurie Toich, Assistant Editor

Patients with chronic hepatitis C virus have an increased risk of developing B-cell lymphomas.

Gene therapy injections improve vision in patients with choroideremia.

Patients with chronic hepatitis C virus have an increased risk of developing B-cell lymphomas.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

No cognitive differences seen between normal mice and fragile X models treated with Nutlin-3.

Sharing genetic and clinical information from cancer patients could allow researchers to better personalize cancer treatments.

Salt-inducible kinases found to limit the production of inflammatory molecules in human immune systems.

The JAK/STAT pathway inhibitor Jakinibs stops the degradation in the substantia nigra that occurs in Parkinson’s disease.

Nanoparticles show promise delivering antiobesity drugs directly into fat tissue.

Anavex 2-73, which is already in clinical trials for Alzheimer’s disease, recently received Orphan Drug Designation from the FDA for a rare genetic neurodevelopmental disorder.

By using data from the federal earned income tax credit, the IRS could sign up low-income persons for Medicaid.

Renal transplant recipients eligible for medication management services under Medicare Part D had higher adherence to medication than ineligible patients.

Epigenetic changes can leave cancer stem cells vulnerable to a combination of 5-azacytidine and butyrate.

Though buprenorphine can be abused, many experts believe prescribing should expand but include more safety guidelines.

HBV treatment for children infected by their mothers could be administered through a series of shots.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

Military veterans are likely to delay seeking healthcare possibly due to the VA health system.

UnitedHealthcare’s withdrawal will leave 3.7% of the state’s current customers needing to find a new insurer.

Research evaluates translating immunotherapy from trials to real world outcomes.

Various approaches needed for immunotherapy efficacy to translate into significant real world outcomes.

Patients with both HIV and cancer are less likely to receive treatment for common cancers, regardless of insurance status.

Targaprimir-96 causes programmed cell death in breast cancer animal models.

Aerosolized SERCA2a gene shown to stop pulmonary hypertension in animal models.

Trifluoperazine, doxapram, and amoxapine effectively treated antibiotic-resistant Yersinia pestis.

Top news of the day from across the healthcare landscape.

Ibrutinib evaluated in the treatment of chronic lymphocytic leukemia, Waldenström macroglobulinaemia, and mantle cell lymphoma.

Limiting the HCV cure to patients with advanced stages of the disease is reviewed.

Minihepcidins show potential to treat blood disorders, beta-thalassemia, and polycythemia vera.